Pub Date : 2022-04-01DOI: 10.4274/vhd.galenos.2022.2020-12-5
Sanem Karadağ Gencer
{"title":"Comparison of Hepatitis B and Hepatitis C Seropositivity of the Syrian Immigrant and Turkish Local People","authors":"Sanem Karadağ Gencer","doi":"10.4274/vhd.galenos.2022.2020-12-5","DOIUrl":"https://doi.org/10.4274/vhd.galenos.2022.2020-12-5","url":null,"abstract":"","PeriodicalId":42346,"journal":{"name":"Viral Hepatit Dergisi-Viral Hepatitis Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46225119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01DOI: 10.4274/vhd.galenos.2021.2020-11-5
Z. Erdogan, M. Kurçer
{"title":"The Effect of Dietary Supplement Use on Quality of Life and Depression in Patients with Chronic Liver Disease: A Cross-Sectional Study","authors":"Z. Erdogan, M. Kurçer","doi":"10.4274/vhd.galenos.2021.2020-11-5","DOIUrl":"https://doi.org/10.4274/vhd.galenos.2021.2020-11-5","url":null,"abstract":"","PeriodicalId":42346,"journal":{"name":"Viral Hepatit Dergisi-Viral Hepatitis Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43768721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01DOI: 10.4274/vhd.galenos.2022.2021-3-2
Müge Toygar Deniz, S. Akhan, M. Sayan, Gülden Sönmez Tamer, Emel Azak
Objectives: Recently, with the use of direct-acting antivirals (DAA) for treating chronic hepatitis C (CHC), the success rate has exceeded 90%. The implementation of these strong therapies has reduced the role of monitoring therapy with hepatitis C virus (HCV)-RNA tests. The current study compares the HCV-core antigen test (HCV-Ag) with HCV-RNA in terms of correlation, effectiveness and cost in patients who started DAA and to evaluate the usability of HCV-Ag as a routine laboratory test. Materials and Methods: This study includes 76 patients with CHC. Patients with positive HCV-RNA, over 18 years old and who will initiate DAA are included. HCV-Ag level was studied in all samples by using ARCHITECT core antigen measurement Abbott method. HCV-RNA and anti-HCV levels compared with HCV-Ag levels. Results: Of the 76 patients, 44 (57%) were males, 48 (63%) were treatment experienced and 21 (27%) were cirrhotic. All patients were started with DAAs. When compared before and after treatment, HCV-RNA level, HCV-Ag level was found to be significantly different (p<0.001). Before treatment, HCV-RNA and HCV-Ag levels were found to be positive correlations (correlation coefficient: 0.419). Conclusion: The use of DAAs in HCV therapy has eliminated the need for response-guided therapy. It has been demonstrated in the study that HCV-Ag measurement is very successful and cost effective in detecting viremic patients and evaluating virological response, which are the two most important factors in the management of CHC.
{"title":"Evaluation of HCV-Core Antigen in Diagnosis of Chronic Hepatitis C Patients under Direct-Acting Antiviral Treatment","authors":"Müge Toygar Deniz, S. Akhan, M. Sayan, Gülden Sönmez Tamer, Emel Azak","doi":"10.4274/vhd.galenos.2022.2021-3-2","DOIUrl":"https://doi.org/10.4274/vhd.galenos.2022.2021-3-2","url":null,"abstract":"Objectives: Recently, with the use of direct-acting antivirals (DAA) for treating chronic hepatitis C (CHC), the success rate has exceeded 90%. The implementation of these strong therapies has reduced the role of monitoring therapy with hepatitis C virus (HCV)-RNA tests. The current study compares the HCV-core antigen test (HCV-Ag) with HCV-RNA in terms of correlation, effectiveness and cost in patients who started DAA and to evaluate the usability of HCV-Ag as a routine laboratory test. Materials and Methods: This study includes 76 patients with CHC. Patients with positive HCV-RNA, over 18 years old and who will initiate DAA are included. HCV-Ag level was studied in all samples by using ARCHITECT core antigen measurement Abbott method. HCV-RNA and anti-HCV levels compared with HCV-Ag levels. Results: Of the 76 patients, 44 (57%) were males, 48 (63%) were treatment experienced and 21 (27%) were cirrhotic. All patients were started with DAAs. When compared before and after treatment, HCV-RNA level, HCV-Ag level was found to be significantly different (p<0.001). Before treatment, HCV-RNA and HCV-Ag levels were found to be positive correlations (correlation coefficient: 0.419). Conclusion: The use of DAAs in HCV therapy has eliminated the need for response-guided therapy. It has been demonstrated in the study that HCV-Ag measurement is very successful and cost effective in detecting viremic patients and evaluating virological response, which are the two most important factors in the management of CHC.","PeriodicalId":42346,"journal":{"name":"Viral Hepatit Dergisi-Viral Hepatitis Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44114296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01DOI: 10.4274/vhd.galenos.2021.2021-7-1
I. Yıldız, I. Bahceci, Tuba İlgar, M. Beyazal, U. Kostakoğlu, A. Ertürk
{"title":"Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?","authors":"I. Yıldız, I. Bahceci, Tuba İlgar, M. Beyazal, U. Kostakoğlu, A. Ertürk","doi":"10.4274/vhd.galenos.2021.2021-7-1","DOIUrl":"https://doi.org/10.4274/vhd.galenos.2021.2021-7-1","url":null,"abstract":"","PeriodicalId":42346,"journal":{"name":"Viral Hepatit Dergisi-Viral Hepatitis Journal","volume":"1 1","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42751870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01DOI: 10.4274/vhd.galenos.2022.2021-7-2
H. Emiroğlu, M. Emiroğlu
{"title":"Efficacy of Entecavir Treatment in a 8-Year-Old Child with Chronic Hepatitis B","authors":"H. Emiroğlu, M. Emiroğlu","doi":"10.4274/vhd.galenos.2022.2021-7-2","DOIUrl":"https://doi.org/10.4274/vhd.galenos.2022.2021-7-2","url":null,"abstract":"","PeriodicalId":42346,"journal":{"name":"Viral Hepatit Dergisi-Viral Hepatitis Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49060978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-01DOI: 10.4274/vhd.galenos.2021.2020-12-9
Y. Gülseren, Fatma Kılıç, Fatma Esenkaya Taşbent
{"title":"A Study of the Hepatitis B Frequency and Its Possible Adverse Outcomes on Pregnancy at a University Hospital","authors":"Y. Gülseren, Fatma Kılıç, Fatma Esenkaya Taşbent","doi":"10.4274/vhd.galenos.2021.2020-12-9","DOIUrl":"https://doi.org/10.4274/vhd.galenos.2021.2020-12-9","url":null,"abstract":"","PeriodicalId":42346,"journal":{"name":"Viral Hepatit Dergisi-Viral Hepatitis Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44328090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-12-23DOI: 10.4274/vhd.galenos.2021.2021-5-7
S. Tosun, S. Deveci, E. Kasırga
1University of Health Sciences Turkey, İzmir Bozyaka Training and Research Hospital, Clinic of Infectious Diseases and Microbiology, İzmir, Turkey 2Şehzadeler County Directorate of Health, Public Health Specialist, Manisa, Turkey 3Manisa Celal Bayar University Faculty of Medicine, Department of Pediatric Gastroenterology, Manisa, Turkey Effect of a Nationwide Universal HBV Vaccination Program and Catch-up Vaccination Campaign on HBV Prevalence in Children
{"title":"Effect of a Nationwide Universal HBV Vaccination Program and Catch-up Vaccination Campaign on HBV Prevalence in Children","authors":"S. Tosun, S. Deveci, E. Kasırga","doi":"10.4274/vhd.galenos.2021.2021-5-7","DOIUrl":"https://doi.org/10.4274/vhd.galenos.2021.2021-5-7","url":null,"abstract":"1University of Health Sciences Turkey, İzmir Bozyaka Training and Research Hospital, Clinic of Infectious Diseases and Microbiology, İzmir, Turkey 2Şehzadeler County Directorate of Health, Public Health Specialist, Manisa, Turkey 3Manisa Celal Bayar University Faculty of Medicine, Department of Pediatric Gastroenterology, Manisa, Turkey Effect of a Nationwide Universal HBV Vaccination Program and Catch-up Vaccination Campaign on HBV Prevalence in Children","PeriodicalId":42346,"journal":{"name":"Viral Hepatit Dergisi-Viral Hepatitis Journal","volume":" ","pages":""},"PeriodicalIF":0.1,"publicationDate":"2021-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43519869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：